A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis
A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis have?
A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis has 15 citations in the OpenAlex counts ScholarIQ stores.
When was A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis published?
A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis has 2024 year in the ScholarIQ index.
What is the open-access status of A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis?
A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis has gold oa status in the ScholarIQ index.
What is the DOI of A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis?
The DOI for A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis is on the source record.
What is the PMID of A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis?
The PMID for A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis is on the source record.
What is the OpenAlex record for A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis?
The OpenAlex for A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis is on the source record.